Herceptin boost to battle against breast cancer
Herceptin became available in Ireland last year to treat the early stages of an aggressive form of breast cancer called HER2 which affects a third of all breast cancer patients, or almost 420 Irish women each year.
Research published this week shows the drug eradicates tumours in over half — 55% — of women suffering from inflammatory HER2 when it is used before chemotherapy.
Lunchtime News
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.



